Advisory Committee on the Medical Uses of Isotopes: Call for Nominations, 71365-71366 [2022-25403]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 224 / Tuesday, November 22, 2022 / Notices
Federal Regulations (10 CFR) the NRC is
providing notice of the receipt of the
application; providing the opportunity
to submit written comments concerning
the application; and providing the
opportunity to request a hearing or
petition for leave to intervene, for a
period of 30 days after publication of
this notice in the Federal Register.
A hearing request or petition for leave
to intervene must include the
information specified in 10 CFR
110.82(b). Any request for hearing or
petition for leave to intervene shall be
served by the requestor or petitioner in
accordance with 10 CFR 110.89(a),
either by delivery, by mail, or filed with
the NRC electronically in accordance
with the NRC’s E-Filing rule (72 FR
49139; August 28, 2007, as amended at
77 FR 46562; August 3, 2012). Detailed
guidance on making electronic
submissions may be found in the
Guidance for Electronic Submissions to
the NRC and on the NRC website at
https://www.nrc.gov/site-help/esubmittals.html.
To comply with the procedural
requirements of E-Filing, at least 10
days prior to the filing deadline, the
participant should contact the Office of
the Secretary by email at
Hearing.Docket@nrc.gov, or by
telephone at 301–415–1677, to (1)
request a digital identification (ID)
certificate, which allows the participant
71365
(or its counsel or representative) to
digitally sign submissions and access
the E-Filing system for any proceeding
in which it is participating; and (2)
advise the Secretary that the participant
will be submitting a petition or other
adjudicatory document (even in
instances in which the participant, or its
counsel or representative, already holds
an NRC-issued digital ID certificate).
Based upon this information, the
Secretary will establish an electronic
docket for the hearing in this proceeding
if the Secretary has not already
established an electronic docket.
The information concerning this
application for an export license
follows:
NRC EXPORT LICENSE APPLICATION
Application Information
Name of Applicant.
Date of Application.
Date Received
Application No
Docket No .....
ADAMS Accession No.
Perma-Fix Northwest Richland, Inc. (PFNW).
October 12, 2022.
October 17, 2022.
XW027/01.
11006380.
ML22292A007.
Description of Material
Material Type
Total Quantity
End Use ........
Country of
Destination.
The incoming material from Germany consists of liquid, shredded and combustible material produced from research, medical,
and other industries (excluding nuclear power plants). After treatment by PFNW, radioactive waste returned to Germany will
consist of residual ash and residual metal or non-combustible material that cannot be recycled. Radionuclides in the waste include carbon-14, cesium-137, cobalt-60, nickel-63, radium-226, and strontium-90.
Authorization to export a total maximum quantity of waste will not exceed 800,000 kilograms. The maximum activity returned to
the originating Eckert and Ziegler Nuclitech GmbH facility will not exceed 8.5 TBq.
Disposal in Germany.
Germany.
Dated: November 17, 2022.
For the Nuclear Regulatory Commission.
Peter J. Habighorst,
Acting Deputy Director, Office of
International Programs.
The U.S. Nuclear Regulatory
Commission (NRC) is soliciting
nominations for the position of
Radiation Oncologist Physician
(Brachytherapy) on the Advisory
Committee on the Medical Uses of
Isotopes (ACMUI). Nominees should be
currently practicing radiation
oncologists.
SUMMARY:
[FR Doc. 2022–25376 Filed 11–21–22; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
khammond on DSKJM1Z7X2PROD with NOTICES
Advisory Committee on the Medical
Uses of Isotopes: Call for Nominations
U.S. Nuclear Regulatory
Commission.
ACTION: Call for Nominations.
AGENCY:
VerDate Sep<11>2014
17:48 Nov 21, 2022
Nominations are due on or
before January 23, 2023.
Nomination Process: Submit an
electronic copy of resume or curriculum
vitae, along with a cover letter, to Dr.
Celimar Valentin-Rodriguez,
celimar.valentin-rodriguez@nrc.gov. The
cover letter should describe the
nominee’s current duties and
DATES:
Jkt 259001
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
responsibilities and express the
nominee’s interest in the position.
Please ensure that the resume or
curriculum vitae includes the following
information, if applicable: education;
certification(s); professional association
and committee membership activities;
duties and responsibilities in current
and previous clinical, research, and/or
academic position(s).
Dr.
Celimar Valentin-Rodriguez, U.S.
Nuclear Regulatory Commission, Office
of Nuclear Material Safety and
Safeguards; (301) 415–7124;
celimar.valentin-rodriguez@nrc.gov.
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\22NON1.SGM
22NON1
71366
Federal Register / Vol. 87, No. 224 / Tuesday, November 22, 2022 / Notices
ACMUI
members possess the medical and
technical skills needed to address
evolving issues. The current
membership is comprised of the
following professionals: (a) nuclear
medicine physician; (b) nuclear
cardiologist; (c) two radiation
oncologists; (d) diagnostic radiologist;
(e) therapy medical physicist; (f) nuclear
medicine physicist; (g) nuclear
pharmacist; (h) health care
administrator; (i) radiation safety officer;
(j) patients’ rights advocate; (k) Food
and Drug Administration representative;
and (l) Agreement State representative.
For additional information about
membership on the ACMUI, visit the
ACMUI Membership web page, https://
www.nrc.gov/about-nrc/regulatory/
advisory/acmui/membership.html.
The ACMUI brachytherapy radiation
oncologist provides advice on issues
associated with radiation oncology and
the clinical use of brachytherapy,
including the use of permanently
implanted microspheres. This advice
includes providing input on NRC
proposed rules and guidance, providing
recommendations on the training and
experience requirements for physicians
specializing in this use, identifying
medical events associated with this use,
evaluating non-routine uses of
byproduct material and emerging
medical technologies, bringing key
issues in the radiation oncology
community to the attention of NRC staff,
and other radiation oncology issues as
they relate to radiation safety and NRC
medical use policy.
The ACMUI advises the NRC on
policy and technical issues that arise in
the regulation of the medical use of
byproduct material. Responsibilities of
an ACMUI member include providing
comments on changes to the NRC
regulations and guidance; evaluating
certain non-routine uses of byproduct
material; providing technical assistance
in licensing, inspection, and
enforcement cases; and bringing key
issues to the attention of the NRC staff,
for appropriate action. Committee
members currently serve a four-year
term and may be considered for
reappointment to an additional term.
Nominees must be U.S. citizens and
be able to devote approximately 160
hours per year to ACMUI business.
Members are expected to attend semiannual meetings at NRC headquarters in
Rockville, Maryland and to participate
in teleconferences or virtual meetings,
as needed. Members who are not
Federal employees at the time of their
appointment are compensated for their
service. In addition, members are
reimbursed for travel (including per
khammond on DSKJM1Z7X2PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
17:48 Nov 21, 2022
Jkt 259001
diem in lieu of subsistence) and are
reimbursed secretarial and
correspondence expenses. Full-time
Federal employees are reimbursed for
travel expenses only.
Security Background CHECK: The
selected nominee will undergo a
thorough security background check.
Security paperwork may take the
nominee several weeks to complete.
Nominees will also be required to
complete a financial disclosure
statement to avoid conflicts of interest.
Dated at Rockville, Maryland, this 17th day
of November, 2022.
For the U.S. Nuclear Regulatory
Commission.
Brooke P. Clark,
Secretary of the Commission.
[FR Doc. 2022–25403 Filed 11–21–22; 8:45 am]
BILLING CODE 7590–01–P
POSTAL REGULATORY COMMISSION
[Docket Nos. MC2023–47 and CP2023–45]
New Postal Products
Postal Regulatory Commission.
Notice.
AGENCY:
ACTION:
The Commission is noticing a
recent Postal Service filing for the
Commission’s consideration concerning
a negotiated service agreement. This
notice informs the public of the filing,
invites public comment, and takes other
administrative steps.
DATES: Comments are due: November
23, 2022.
ADDRESSES: Submit comments
electronically via the Commission’s
Filing Online system at https://
www.prc.gov. Those who cannot submit
comments electronically should contact
the person identified in the FOR FURTHER
INFORMATION CONTACT section by
telephone for advice on filing
alternatives.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
David A. Trissell, General Counsel, at
202–789–6820.
SUPPLEMENTARY INFORMATION:
Table of Contents
I. Introduction
II. Docketed Proceeding(s)
I. Introduction
The Commission gives notice that the
Postal Service filed request(s) for the
Commission to consider matters related
to negotiated service agreement(s). The
request(s) may propose the addition or
removal of a negotiated service
agreement from the Market Dominant or
the Competitive product list, or the
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
modification of an existing product
currently appearing on the Market
Dominant or the Competitive product
list.
Section II identifies the docket
number(s) associated with each Postal
Service request, the title of each Postal
Service request, the request’s acceptance
date, and the authority cited by the
Postal Service for each request. For each
request, the Commission appoints an
officer of the Commission to represent
the interests of the general public in the
proceeding, pursuant to 39 U.S.C. 505
(Public Representative). Section II also
establishes comment deadline(s)
pertaining to each request.
The public portions of the Postal
Service’s request(s) can be accessed via
the Commission’s website (https://
www.prc.gov). Non-public portions of
the Postal Service’s request(s), if any,
can be accessed through compliance
with the requirements of 39 CFR
3011.301.1
The Commission invites comments on
whether the Postal Service’s request(s)
in the captioned docket(s) are consistent
with the policies of title 39. For
request(s) that the Postal Service states
concern Market Dominant product(s),
applicable statutory and regulatory
requirements include 39 U.S.C. 3622, 39
U.S.C. 3642, 39 CFR part 3030, and 39
CFR part 3040, subpart B. For request(s)
that the Postal Service states concern
Competitive product(s), applicable
statutory and regulatory requirements
include 39 U.S.C. 3632, 39 U.S.C. 3633,
39 U.S.C. 3642, 39 CFR part 3035, and
39 CFR part 3040, subpart B. Comment
deadline(s) for each request appear in
section II.
II. Docketed Proceeding(s)
1. Docket No(s).: MC2023–47 and
CP2023–45; Filing Title: USPS Request
to Add Priority Mail, First-Class Package
Service & Parcel Select Contract 4 to
Competitive Product List and Notice of
Filing Materials Under Seal; Filing
Acceptance Date: November 15, 2022;
Filing Authority: 39 U.S.C. 3642, 39 CFR
3040.130 through 3040.135, and 39 CFR
3035.105; Public Representative:
Christopher C. Mohr; Comments Due:
November 23, 2022.
This Notice will be published in the
Federal Register.
Erica A. Barker,
Secretary.
[FR Doc. 2022–25335 Filed 11–21–22; 8:45 am]
BILLING CODE 7710–FW–P
1 See Docket No. RM2018–3, Order Adopting
Final Rules Relating to Non-Public Information,
June 27, 2018, Attachment A at 19–22 (Order No.
4679).
E:\FR\FM\22NON1.SGM
22NON1
]]>Agencies
[Federal Register Volume 87, Number 224 (Tuesday, November 22, 2022)]
[Notices]
[Pages 71365-71366]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-25403]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Call for
Nominations
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Call for Nominations.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is soliciting
nominations for the position of Radiation Oncologist Physician
(Brachytherapy) on the Advisory Committee on the Medical Uses of
Isotopes (ACMUI). Nominees should be currently practicing radiation
oncologists.
DATES: Nominations are due on or before January 23, 2023.
Nomination Process: Submit an electronic copy of resume or
curriculum vitae, along with a cover letter, to Dr. Celimar Valentin-
Rodriguez, [email protected]. The cover letter should
describe the nominee's current duties and responsibilities and express
the nominee's interest in the position. Please ensure that the resume
or curriculum vitae includes the following information, if applicable:
education; certification(s); professional association and committee
membership activities; duties and responsibilities in current and
previous clinical, research, and/or academic position(s).
FOR FURTHER INFORMATION CONTACT: Dr. Celimar Valentin-Rodriguez, U.S.
Nuclear Regulatory Commission, Office of Nuclear Material Safety and
Safeguards; (301) 415-7124; [email protected].
[[Page 71366]]
SUPPLEMENTARY INFORMATION: ACMUI members possess the medical and
technical skills needed to address evolving issues. The current
membership is comprised of the following professionals: (a) nuclear
medicine physician; (b) nuclear cardiologist; (c) two radiation
oncologists; (d) diagnostic radiologist; (e) therapy medical physicist;
(f) nuclear medicine physicist; (g) nuclear pharmacist; (h) health care
administrator; (i) radiation safety officer; (j) patients' rights
advocate; (k) Food and Drug Administration representative; and (l)
Agreement State representative. For additional information about
membership on the ACMUI, visit the ACMUI Membership web page, https://www.nrc.gov/about-nrc/regulatory/advisory/acmui/membership.html.
The ACMUI brachytherapy radiation oncologist provides advice on
issues associated with radiation oncology and the clinical use of
brachytherapy, including the use of permanently implanted microspheres.
This advice includes providing input on NRC proposed rules and
guidance, providing recommendations on the training and experience
requirements for physicians specializing in this use, identifying
medical events associated with this use, evaluating non-routine uses of
byproduct material and emerging medical technologies, bringing key
issues in the radiation oncology community to the attention of NRC
staff, and other radiation oncology issues as they relate to radiation
safety and NRC medical use policy.
The ACMUI advises the NRC on policy and technical issues that arise
in the regulation of the medical use of byproduct material.
Responsibilities of an ACMUI member include providing comments on
changes to the NRC regulations and guidance; evaluating certain non-
routine uses of byproduct material; providing technical assistance in
licensing, inspection, and enforcement cases; and bringing key issues
to the attention of the NRC staff, for appropriate action. Committee
members currently serve a four-year term and may be considered for
reappointment to an additional term.
Nominees must be U.S. citizens and be able to devote approximately
160 hours per year to ACMUI business. Members are expected to attend
semi-annual meetings at NRC headquarters in Rockville, Maryland and to
participate in teleconferences or virtual meetings, as needed. Members
who are not Federal employees at the time of their appointment are
compensated for their service. In addition, members are reimbursed for
travel (including per diem in lieu of subsistence) and are reimbursed
secretarial and correspondence expenses. Full-time Federal employees
are reimbursed for travel expenses only.
Security Background CHECK: The selected nominee will undergo a
thorough security background check. Security paperwork may take the
nominee several weeks to complete. Nominees will also be required to
complete a financial disclosure statement to avoid conflicts of
interest.
Dated at Rockville, Maryland, this 17th day of November, 2022.
For the U.S. Nuclear Regulatory Commission.
Brooke P. Clark,
Secretary of the Commission.
[FR Doc. 2022-25403 Filed 11-21-22; 8:45 am]
BILLING CODE 7590-01-P
